Pharma Marketing Meetings
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Conference Calendar Reader Surveys

Share |

Featured Conference
7 - 8 April 2015 | Philadelphia, PA
Collaborate to succeed in customer-driven healthcare

This US leading commercial pharma event is back for a 13th successful year - and a clear mission: to facilitate collaboration and enable pharma to become a sustainable partner in customer-driven healthcare. The summit will feature 3 interconnected tracks with 45+ sessions on value partnerships, marketing and sales capabilities and patient engagement. Learn more...
January 2015
PCC 2015 - CBI's 12th Annual Pharmaceutical Compliance Congress
PCC 2015 - CBI's 12th Annual Pharmaceutical Compliance Congress

Widely recognized as the most comprehensive, senior-level compliance meeting, CBI's esteemed Pharmaceutical Compliance Congress (PCC) attracts more than 400 industry leaders, including dozens of CCOs and their legal, compliance and regulatory teams.
27 - 28 January 2015 | Washington, DC

Big Data in Pharma Europe
Big Data in Pharma Europe

Taking the Next Steps on the Big Data Journey to Revolutionise Value-Based Personalised Healthcare
27 - 29 January 2015 | London, UK

10th Annual Summit on Biosimilars
10th Annual Summit on Biosimilars

Analyze the Regulatory Landscape and Maximize Commercial Potential to Achieve Market Access
29 - 30 January 2015 | Alexandria, VA
February 2015
Expanded Access Programs
Expanded Access Programs

Strategies to create regulatory-compliant and equitable access programs for patients with unmet medical needs.
3 - 4 February 2015 | Philadelphia, PA

4th Hub Models and Program Design
4th Hub Models and Program Design

New Approaches and Hub Strategies to Optimize Patient Services and Program Effectiveness
5 - 6 February 2015 | Philadelphia, PA

6th Patient Adherence and Advocacy Summit
6th Patient Adherence and Advocacy Summit

Working Hand in Hand with All Stakeholders to Leverage Innovative Approaches to Improve Adherence in the Changing Healthcare Landscape
23 - 24 February 2015 | Philadelphia, PA

8th Annual Oncology Commercialization & Market Access
8th Annual Oncology Commercialization & Market Access

Demonstrate Value, Navigate Payment Reform and Maximize Product Uptake
24 - 26 February 2015 | San Francisco, CA

Sample Compliance and Reporting Summit
Sample Compliance and Reporting Summit

Establish Effective Protocols to Enhance Analytics, Mitigate Risk and Increase Efficiency
25 - 26 February 2015 | Philadelphia, PA

Speaker Programs 2015
Speaker Programs 2015

The Evolution of Speaker Programs in the Wake of The Open Payments Data Release and Advances in Technology
25 - 26 February 2015 | Philadelphia, PA

Exchange Access Strategies
Exchange Access Strategies

Plan Coverage • Contract Structures • Coupons and Cost Sharing • Formulary Nuances
26 February 2015 | Philadelphia, PA
March 2015
PAP 2015 - 16th Patient Assistance and Access Programs
PAP 2015 - 16th Patient Assistance and Access Programs

Ensure Prescription Drug Coverage, Financial Support and Access to Care for Uninsured and Underinsured Patients
2 - 4 March 2015 | Baltimore, MD

Social Media and Digital Platforms Compliance Strategies Summit
Social Media and Digital Platforms Compliance Strategies Summit

Mitigate Enforcement Risks with Disease Education and Bio/Pharma Digital and Social Promotion
10 - 11 March 2015 | Philadelphia, PA

Compliance Monitoring Programs
Compliance Monitoring Programs

Signal Experiences and Best Practices for Signal Detection, Issue Spotting and Risk Mitigation
18 - 19 March 2015 | Philadelphia, PA

Pharma Forum 2015
Pharma Forum 2015

Where Meeting Managers Unite for Education, Collaboration and Innovation
22 - 25 March 2015 | National Harbor, MD

13th Annual eyeforpharma Barcelona 2015
13th Annual eyeforpharma Barcelona 2015

Your Customer is in Charge!
24 - 26 March 2015 | Barcelona, Spain


eRX and HER
eRX and HER

Leverage Opportunities for Promotional Effectiveness
25 - 26 March 2015 | Philadelphia, PA

Third Party Risk, Audits and Oversight
Third Party Risk, Audits and Oversight

Evaluate Distributors, Agents, Logistics and other 3rd Parties in the Life Science Industry
25 - 26 March 2015 | Philadelphia, PA
April 2015
13th Annual eyeforpharma Philadelphia 2015
13th Annual eyeforpharma Philadelphia 2015

Explore how pharma is improving health outcomes through collaboration, innovation and technology.
7 - 8 April 2015 | Philadelphia, PA

Global Transparency Reporting Congress
Global Transparency Reporting Congress

Evolving Guidelines for Disclosing HCP Spend Across the Globe
15 - 16 April 2015 | London, UK

Real-Time Benefit Verification and ePrior Authorization
Real-Time Benefit Verification and ePrior Authorization

Next Steps for Formulary and Coverage Visibility
21 - 22 April 2015 | Philadelphia, PA

Transparency Reporting West
Transparency Reporting West

Process & System Innovation for Compliance & Commercial Excellence
22 - 23 April 2015 | San Diego, CA

Life Sciences Advisory Boards Strategy and Efficiency Summit
Life Sciences Advisory Boards Strategy and Efficiency Summit

Build Comprehensive Boards to Maximize Advisor Engagement and Maintain Compliance
23 - 24 April 2015 | San Diego, CA

Coupon and Co Pay Master Class
Coupon and Co Pay Master Class

Improve Patient Acquisition and Retention Through Enhanced and Compliant Discount Programs
27 - 28 April 2015 | San Francisco, CA

4th Digital Marketing for Medical Devices West
4th Digital Marketing for Medical Devices West

Leverage Digital to Expand Your Reach, Foster Brand Loyalty and Add Value for Your Customers
27 - 29 April 2015 | San Francisco, CA

Lyophilisation USA
Lyophilisation USA

29 - 30 April 2015 | Iselin, NJ
May 2015
7th Annual Digital Pharma Europe
7th Annual Digital Pharma Europe

Delivering excellence in digital/social marketing, data-driven campaigns, integrating digital and non-digital touch-points, predictive analytics and creating measurable impact on the sales funnel
12 - 14 May 2015 | Rome, Italy

iPharma 2015
iPharma 2015 - CBI's Marketing Innovation Forum

CBI's Marketing Innovation Forum
14 - 15 May 2015 | New York, NY
June 2015
6th Annual Digital Pharma West
6th Annual Digital Pharma West

1 - 3 June 2015 | San Francisco, CA
Scheduled Events

Appropriate Use of Twitter by Pharma
Leigh FazzinaIn this 3-minute audio snippet, Leigh Fazzina, Principal, Fazzina & Co. Communications Consulting, Inc., talks about how social media listening tools can help pharma marketers identify online patient and physician opinion leaders in specific disease categories.


Messages from Our Sponsors

Pharma Marketing News

Selected Content from Recent Issues of Pharma Marketing News

Are Drug.com Websites "Fair and Balanced?"
FDA Studies Online DTC Prescription Drug Promotion

Fair and Balanced Drug.com

According to Internet analytics provider comScore, patients who visit a drug brand's website are more likely to end up taking that drug than those who don't. FDA is aware of this and cited a Prevention Magazine 2011 survey that found that 49 percent of respondents who went online for prescription drug information reported seeking this information on a specific brand's Web site.

As a consequence of this influence of the Internet, FDA is currently studying how consumers interact with drug.com websites. Specifically, according to an April, 2011, public notice, FDA has a number of questions surrounding how to achieve "fair balance" in online DTC promotion.

This article reviews the study "Examination of Online Direct-to-Consumer Prescription Drug Promotion" (FDA-2011-N-0230), which is designed to test different ways of presenting prescription drug risk and benefit information on branded drug Web sites.

Topics include (partial list):
  • Is FDA Out of Touch?
  • Format & Visibility of ISI
  • Table: Recent Rx Drug Advertising Studies proposed by FDA
  • What About Online Testimonials?
  • To Link or Not To Link?
  • Impact on Internet Guidance
Download the full text PDF file here:
http://bit.ly/pmn131001p

Does Your Spouse Influence Your DTC Viewing Experience?
FDA Wants to Peek Into Your Bedroom

Spousal Influence

FDA's Office of Prescription Drug Promotion (OPDP) plans to examine differences between consumers viewing prescription drug ads with a spouse versus alone.

In its Federal Register notice about the "Spousal Influence" study ("Spousal Influence on Consumer Understanding of and Response to Direct-To-Consumer Prescription Drug Advertisements"; FDA-2014-N-1819), FDA presented this premise:

"Judgments about prescription drugs portrayed in DTC ads are likely made in social contexts much of the time. For example, a potential consumer and his or her spouse (e.g., marital or domestic partner) may view an ad together and discuss drug benefits, side effects, and risks. These social interactions may result in unique reactions relative to consumers who view DTC prescription drug ads alone."

This article is a review of that study.

Topics include (partial list):
  • Study Design
  • A Missed Opportunity
  • Impact on Regulation of Ads
  • A Viagra Ad Your Spouse May Not Want You to See
Download the full text PDF file here:
http://bit.ly/pmn131003p


Use this Form to request a listing for your conference or event

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.